US OPEN: Wall Street set for a flat open as virus worries persist

4:55 pm 10 February 2020

  • US stock index futures point to a flat open on Wall Street

  • Tesla (TSLA.US) gains as operations at Shanghai factory are resumed

  • L Brands (LB.US) may sell Victoria’s Secret brand to private equity firm

US stock index futures hint at a flat opening of today’s session on Wall Street. Technological Nasdaq is performing slightly better than S&P 500 or Dow Jones in pre-market trade. Traders should expect coronavirus news to be a main driver of today’s moves. Among companies making big moves ahead of session open one can find Tesla and L Brands.

Nasdaq (US100) futures signalling a small bullish gap at the opening of today’s session. The index remains close to all-time highs but has trade sideways in a tight range recently. The range is being limited by 9400 pts handle (support) and 50-hour moving average (resistance). These two levels could be on watch throughout today’s session. Source: xStation5

Some news on Tesla (TSLA.US) surfaced recently. Peter Altmaier, German economy minister, said that Tesla may receive subsidies from the German government for its planned factory near Berlin in case it meets certain preconditions. Those include setting up a R&D department in Germany and meeting sustainability and performance standards for batteries. However, the stock is trading 8% higher in pre-market on other news - it was reported that Gigafactory in Shanghai has resumed operations.

NIO (NIO.US), the Chinese EV manufacturer, announced it has delivered 1598 vehicles in January, marking a 11.5% YoY decline. The company said that coronavirus negatively impacted sales figures. NIO expects production and deliveries to underperform in February as well.

Share price of NIO (NIO.US) took a steep dive in March 2019 and continued to decline until the end of September 2019. The company was recovering in Q4 2019 and January 2019. However, a head and shoulders pattern can be spotted on the chart with 23.6% Fibo level of the aforementioned downward move serving as a neckline. Target of this pattern can be found in the $2.50 area. Source: xStation5

Allergan (AGN.US) released earnings report for Q4 2019 ahead of the session open. Pharmaceutical company generated sales of $4.35 billion, marking a 5.8% beat and 6.6% YoY increase. EPS of $5.22 was 13.5% higher than expected and 21.7% higher than a year ago. The company managed to increase sales of all of its top drugs with Restasis being the only exception (-4.1% YoY). The company expects AbbVie merger to be closed around the end of the Q1 2020.

L Brands (LB.US) is said to be nearing a deal to sell Victoria’s Secret brand to Sycamore, the US private equity firm. CNBC reports that the deal could be announced as soon as this week. Terms of the deal are still being negotiated. Shares of L Brands rise over 7% in pre-session trading.

L Brands (LB.US) failed to break above the resistance zone at $24.65 last week. However, the stock is set to open 7% higher today, thanks to news of Victoria’s Secret deal. This indicates an opening above the aforementioned zone. Should it be so the stock would find itself between two important price zones - $24.65 (support) and $28.00 (resistance). Source: xStation5

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.

Share:
Back

Join over 1 600 000 XTB Group Clients from around the world.